OncoMethylome Appoints New Board Director and New COO

27-Jan-2009 - Belgium

OncoMethylome Sciences announced that Mr. Gerard Vaillant will join its Board of Directors as a replacement to Dr. Christian Schneider, and that Mr. Gert-Jan Renardel de Lavalette has been hired as Chief Operating Officer.

Mr. Gerard Vaillant, will join the Board of Directors of OncoMethylome effective February 19, 2009. Mr. Vaillant has extensive experience in the health care and molecular diagnostics industry. He has served as Group Chairman of Johnson&Johnson (J&J) and Chairman of Ortho-Clinical Diagnostics Inc., Veridex Inc., and Therakos Inc. He has personally managed the development, manufacturing, and commercialization of numerous healthcare products throughout the world. He currently is a Board member of Luminex Corporation (US), Tecan AG (CH), IntegraGen SA (F), Vivacta Ltd. (UK), and Sensors for Medicine and Science, Inc. (US).

Dr. Christian Schneider, a venture capital investor in Europe has been a Board member or Board representative at OncoMethylome since its creation in 2003. He has resigned his position as a director at OncoMethylome in order to be able to devote more time to a new European life sciences venture capital fund and to earlier-stage healthcare companies.

Mr. Gert-Jan Renardel de Lavalette will become the COO of OncoMethylome Sciences starting on February 2, 2009. In this newly created management position at OncoMethylome, Mr. Renardel will focus on the development and commercialization of the numerous products of OncoMethylome. Mr. Renardel brings over 20 years of experience in the diagnostics and pharmaceutical industry from his previous management positions at Schering-Plough and Akzo Nobel.

https://www.bionity.com/en/news/94245/oncomethylome-appoints-new-board-director-and-new-coo.html